Clinical Trials Directory

Trials / Completed

CompletedNCT00182975

Effects of Dehydroepiandrosterone (DHEA) in Humans

Is DHEA Replacement Beneficial?

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
142 (actual)
Sponsor
National Institute on Aging (NIA) · NIH
Sex
All
Age
65 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether bringing back the DHEA levels of older persons to the young range produces beneficial effects.

Detailed description

DHEA and DHEA sulfate (DHEAS) plasma concentrations peak at about 20 years of age and decline rapidly and markedly after age 25 yr. DHEA is a PPAR-alpha activator. PPAR-alpha plays major roles in regulating lipid metabolism and controlling inflammation. DHEA also appears to have anabolic effects on muscle and bone. The study is designed to determine the effects of 12 months of DHEA replacement in 65-75 year old women and men on (a) truncal and visceral fat, (b) insulin resistance and serum triglycerides, (c) muscle mass and strength, (d) bone mineral density, (e) chronic inflammation, (f) arterial-endothelium-dependent vasodilation, and (g) sense of well being. The specific aims of this study are to test the hypotheses that 12 months of DHEA replacement will (a) Result in significant decreases in truncal and visceral fat by shifting metabolism to fat oxidation and increasing energy wastage; (b) Decrease insulin resistance and decrease serum triglycerides; (c) Increase muscle mass and strength, by decreasing catabolic stimuli and increasing anabolic stimuli; (d) Increase bone mineral density by increasing anabolic stimuli and decreasing catabolic stimuli; (e) Reduce chronic inflammation and decrease pro-inflammatory cytokine production by peripheral blood mononuclear cells; (f) Improve arterial endothelium dependent vasodilation; and (g) Improve general sense of well being.

Conditions

Interventions

TypeNameDescription
DRUGDHEA replacement

Timeline

Start date
2002-09-01
Primary completion
2007-09-01
Completion
2007-09-01
First posted
2005-09-16
Last updated
2008-08-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00182975. Inclusion in this directory is not an endorsement.